| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.5× | −1.7× | |
| Price / Book | 2.1× | 2.0× | |
| Price / Sales | 7.8× | 3.9× | |
| Price / Free cash flow | −0.5× | −1.6× | |
| EV / EBITDA | −0.3× | −1.2× | |
| Earnings yield | −217.3% | −14.3% | |
| Free cash flow yield | −191.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,266.87 | +2.14% | $1.19T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $256.43 | +1.04% | $617.97B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $286.20 | +1.25% | $505.75B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $409.53 | +0.65% | $367.59B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.63 | −1.59% | $354.36B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.07 | +1.25% | $280.34B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $166.86 | +1.77% | $258.78B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.47 | +0.75% | $253.08B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.72 | +0.65% | $231.24B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.29 | +1.45% | $192.55B | 22.3× | 37.5% | +29.9% |
